Ketazed

Ketotifen hydrogen fumarate, the active ingredient in Ketazed, is an antihistamine (H1 receptor antagonist) presented as an ocular solution for eye‑drop use. It is indicated for the relief of allergic conjunctivitis and associated ocular itching, redness, and watery discharge in patients with seasonal or perennial eye allergies.

GNH USA supplies Ketazed as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable access to this EU‑approved OTC ocular antihistamine for eye‑care professionals and patients, with consistent quality and regulatory compliance.

Ketazed is used to manage allergic eye conditions by blocking histamine activity in the conjunctiva.

Allergic conjunctivitis: reduces itching, redness, and tearing associated with seasonal or perennial eye allergies. Seasonal allergic eye disease: provides symptom relief during pollen or allergen exposure. Contact lens‑related ocular itching: alleviates discomfort caused by allergic reactions in contact lens wearers.

Ketazed may cause ocular and systemic adverse reactions, most of which are mild and transient.

Common Side Effects: - Eye irritation or burning sensation - Transient blurred vision - Mild headache

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) with swelling of eyelids or face - Corneal ulcer or keratitis - Significant increase in intra‑ocular pressure

Before using Ketazed, consider the following safety measures.

Hypersensitivity: discontinue use if signs of allergic reaction appear. Contact lens use: avoid wearing contact lenses during treatment and for at least 15 minutes after instillation. Dosage: use only the prescribed number of drops as directed by a healthcare professional. Monitoring: seek medical advice if symptoms worsen or persist beyond a few days. Driving or operating machinery: exercise caution if blurred vision occurs. Store at room temperature: keep in original container, protect from moisture and light.

Ketazed can interact with other medicines; review the following categories.

Major Interactions (Avoid): - Systemic antihistamines: concurrent use may increase sedation and ocular dryness. - CYP450 inhibitors (e.g., ketoconazole): may raise systemic exposure of ketotifen. - Other mast‑cell stabilizers: combined use may increase risk of ocular irritation.

Moderate Interactions (Monitor Closely): - Topical corticosteroids: may augment intra‑ocular pressure when used together. - Contact lens cleaning solutions: can affect drug stability; avoid mixing. - Other ocular decongestants: may cause additive vasoconstriction.